Lataa...
BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
β-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the β-secretase enzyme required for the production of the neurotoxic β-amyloid (Aβ) peptide that is widely considered to have a crucial early role in the etiology of Alzheimer’s disease (AD). As a result, BACE1 has emerged as a prime drug...
Tallennettuna:
| Julkaisussa: | Alzheimers Res Ther |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304279/ https://ncbi.nlm.nih.gov/pubmed/25621019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0089-7 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|